GENETRON HOLDINGS LTD-ADR (GTH) Stock Price, Forecast & Analysis
USA - NASDAQ:GTH - US37186H2094 - ADR
GTH Key Statistics, Chart & Performance
The current stock price of GTH is 4.025 USD. In the past month the price increased by 2.68%. In the past year, price increased by 27.78%.
GTH Latest News, Press Relases and Analysis
GTH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.58 | 410.35B | ||
| AMGN | AMGEN INC | 15.36 | 180.89B | ||
| GILD | GILEAD SCIENCES INC | 15.29 | 155.35B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.03 | 111.41B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.44 | 73.66B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 890.14 | 59.51B | ||
| INSM | INSMED INC | N/A | 40.36B | ||
| NTRA | NATERA INC | N/A | 27.54B | ||
| BIIB | BIOGEN INC | 9.84 | 24.15B | ||
| INCY | INCYTE CORP | 16.42 | 20.58B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.52 | 20.91B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 34.49 | 14.30B |
Related stock screener links
About GTH
Company Profile
Genetron Holdings Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 799 full-time employees. The company went IPO on 2020-06-19. Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The firm has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The firm operates its businesses primarily within the China market.
Company Info
GENETRON HOLDINGS LTD-ADR
1-2/F, Building 11, Zone 1, No.8 Life Science Parkway, Changping District
Beijing BEIJING 102206 CN
CEO: Sizhen Wang
Employees: 799
Phone: 861050907500
GENETRON HOLDINGS LTD-ADR / GTH FAQ
Can you describe the business of GENETRON HOLDINGS LTD-ADR?
Genetron Holdings Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 799 full-time employees. The company went IPO on 2020-06-19. Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The firm has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The firm operates its businesses primarily within the China market.
Can you provide the latest stock price for GENETRON HOLDINGS LTD-ADR?
The current stock price of GTH is 4.025 USD. The price increased by 0.12% in the last trading session.
Does GTH stock pay dividends?
GTH does not pay a dividend.
What is the ChartMill technical and fundamental rating of GTH stock?
GTH has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists GTH stock?
GTH stock is listed on the Nasdaq exchange.
What is the analyst forecast for GTH stock?
5 analysts have analysed GTH and the average price target is 1.39 USD. This implies a price decrease of -65.54% is expected in the next year compared to the current price of 4.025.
Should I buy GTH stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GTH.
GTH Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to GTH. When comparing the yearly performance of all stocks, GTH is one of the better performing stocks in the market, outperforming 76.99% of all stocks.
GTH Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GTH. GTH may be in some trouble as it scores bad on both profitability and health.
GTH Financial Highlights
Over the last trailing twelve months GTH reported a non-GAAP Earnings per Share(EPS) of -3.54. The EPS decreased by -61.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.89% | ||
| ROE | -148.03% | ||
| Debt/Equity | 0.05 |
GTH Forecast & Estimates
5 analysts have analysed GTH and the average price target is 1.39 USD. This implies a price decrease of -65.54% is expected in the next year compared to the current price of 4.025.
For the next year, analysts expect an EPS growth of 20.69% and a revenue growth 25.16% for GTH